title: Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results.
abstract: BACKGROUND
  As new treatment modalities develop for the management of vestibular schwannomas (VS) in patients with neurofibromatosis type 2, it remains crucial to ascertain the natural history of the disease.
  
  
  OBJECTIVE
  To determine the relationship between hearing and tumor growth in patients undergoing conservative VS management.
  
  
  METHODS
  Patients harboring bilateral VS with at least 1 year of radiological follow-up were selected. Conservative management was proposed based on the small tumor size and/or serviceable hearing at presentation. Tumor size was calculated by using the 2-component box model and reported as mean tumor diameter. Hearing was evaluated by using pure-tone average and the American Academy of Otololaryngologists and Head and Neck Surgery classification.
  
  
  RESULTS
  Forty-six patients harboring 92 VS were included. The mean clinical and radiological follow-up times were 6.0 and 4.2 years, respectively. The mean tumor diameter was 13 mm at presentation and 20 mm at the end of follow-up. Mean tumor growth rate was 1.8 mm/year. During follow-up, 17 patients (37%) underwent surgery for VS. Surgery-free rate for VS was 88% at 5 years. The number of patients with at least 1 serviceable ear was 39 (85%) at presentation and 34 (74%) at the end of follow-up, including 22 (66%) with binaural serviceable hearing maintained. There was no statistical correlation between tumor growth rate and preservation of serviceable hearing. Tumor growth rates and age at presentation were inversely correlated.
  
  
  CONCLUSIONS
  This study illustrates the high variability among neurofibromatosis type 2 patients regarding hearing status and VS growth rate and justifies the choice of initial conservative management in selected cases.
  
  
  BACKGROUND
  : AAO-HNS, American Academy of Otololaryngologists and Head and Neck Surgery classificationMTD, mean tumor diameterNF2, neurofibromatosis type 2PTA, pure-tone averageSDS, speech discrimination scoreVS, vestibular schwannomas.
authors: AP-HP, Hôpital Beaujon, Department of Neurosurgery, Clichy, France.
authors: Matthieu
authors: M
authors: Peyre
authors: Stéphane
authors: S
authors: Goutagny
authors: Alpha
authors: A
authors: Bah
authors: Daniele
authors: D
authors: Bernardeschi
authors: Béatrice
authors: B
authors: Larroque
authors: Olivier
authors: O
authors: Sterkers
authors: Michel
authors: M
authors: Kalamarides
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D005260:Female; D007839:Functional Laterality; D006311:Hearing Disorders / Q000453:epidemiology* / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016518:Neurofibromatosis 2 / Q000150:complications / Q000473:pathology; D009464:Neuroma, Acoustic / Q000150:complications* / Q000473:pathology; D057832:Watchful Waiting; D055815:Young Adult